Distinguished in Autosomal Recessive Primary Microcephaly

Angela M. Kaindl

Berlin, BE, DE 
Distinguished in Autosomal Recessive Primary Microcephaly
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Angela Kaindl practices in Berlin, Germany. Ms. Kaindl is rated as a Distinguished expert by MediFind in the treatment of Autosomal Recessive Primary Microcephaly. Her top areas of expertise are Autosomal Recessive Primary Microcephaly, Microcephaly, Achalasia Microcephaly Syndrome, Cortical Dysplasia, and Rhizotomy.

Her clinical research consists of co-authoring 159 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 16 articles in the study of Autosomal Recessive Primary Microcephaly.

Gender
Female

Locations

Berlin, BE, Germany
Other Locations
Munich, BY 80337, Germany
Mitte, BE 10115, Germany
Germany
Dresden, SN, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

European Alpha-Mannosidosis Participant: An International, Multicenter, Epidemiological Protocol
European Alpha-Mannosidosis Participant: An International, Multicenter, Epidemiological Protocol
Enrollment Status: Terminated
Publish Date: June 13, 2022
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Enrollment Status: Terminated
Publish Date: August 20, 2018
View 2 Less Clinical Trials

159 Total Publications

Author Correction: Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings.
Author Correction: Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings.
Journal: Nature genetics
Published: June 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kaindl's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 74 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile